Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danbi Lee

Showing results (141-150 of 181) with videos related to

Pageof 19
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 18, 2024
A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis BYeonjung Ha, Seungseok Lee, Jihye Lim, et al.
Liver Cancer|May 31, 2022
Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and RadiotherapyJinhong Jung, Ji Hyeon Joo, So Yeon Kim, et al.
Journal of Medical Virology|March 7, 2016
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysisJihyun An, Ju Hyun Shim, Seon-Ok Kim, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2025
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular CarcinomaKanghee Park, Hye Won Lee, Euichang Kim, et al.
Plos One|November 5, 2020
A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinomaJonggi Choi, So-Hyun Kim, Seungbong Han, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2015
Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular CarcinomaYeonjung Ha, Seungbong Han, Ju Hyun Shim, et al.
Clinical and Molecular Hepatology|April 24, 2014
Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinomaJee Eun Yang, Eunji Park, Hyo Jeong Lee, et al.
Digestive Diseases and Sciences|August 18, 2017
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular CarcinomaJong Kwan Kim, Hyung-Don Kim, Mi-Jung Jun, et al.
Journal of Hepatology|December 23, 2014
Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolizationHyung-Don Kim, Ju Hyun Shim, Gi-Ae Kim, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 24, 2022
Positional scanning of natural product hispidol's ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseasesAhmed H E Hassan, Hyeon Jeong Kim, Min Sung Gee, et al.
Pageof 19

Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Liver International : Official Journal of the International Association for the Study of the Liver|December 18, 2024
A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis BYeonjung Ha, Seungseok Lee, Jihye Lim, et al.
Liver Cancer|May 31, 2022
Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and RadiotherapyJinhong Jung, Ji Hyeon Joo, So Yeon Kim, et al.
Journal of Medical Virology|March 7, 2016
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysisJihyun An, Ju Hyun Shim, Seon-Ok Kim, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2025
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular CarcinomaKanghee Park, Hye Won Lee, Euichang Kim, et al.
Plos One|November 5, 2020
A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinomaJonggi Choi, So-Hyun Kim, Seungbong Han, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2015
Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular CarcinomaYeonjung Ha, Seungbong Han, Ju Hyun Shim, et al.
Clinical and Molecular Hepatology|April 24, 2014
Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinomaJee Eun Yang, Eunji Park, Hyo Jeong Lee, et al.
Digestive Diseases and Sciences|August 18, 2017
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular CarcinomaJong Kwan Kim, Hyung-Don Kim, Mi-Jung Jun, et al.
Journal of Hepatology|December 23, 2014
Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolizationHyung-Don Kim, Ju Hyun Shim, Gi-Ae Kim, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 24, 2022
Positional scanning of natural product hispidol's ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseasesAhmed H E Hassan, Hyeon Jeong Kim, Min Sung Gee, et al.
Pageof 19